INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43m ago
HOUSE PTR3m ago
SEC 13F3m ago
ROBINHOOD CHAIN2m ago
Corporate insider
CT

Clarke Trafford

DirectorCIK 0001958857

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 0
Max Insider Score9
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
CT
Clarke TraffordDirector
TRAWTraws Pharma, Inc.
Grant or award
A—
33.4K sh
Mar 8, 2026Mar 10, 2026
traded Mar 8, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Traws Pharma, Inc.Director · Dec 16, 2025
9
CT
Clarke TraffordDirector
TRAWTraws Pharma, Inc.
Grant or award
A
—
6,157 sh
Dec 12, 2025
Dec 16, 2025
traded Dec 12, 2025
+4d
SEC FORM 4

Evidence

9
CT
Clarke TraffordDirector
TRAWTraws Pharma, Inc.
Grant or award
A—
24.6K sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC FORM 4

Evidence